Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

The Charlesworth Group (USA)

Charlesworth Press is located in Wakefield, West Yorkshire, UK. Printing operations are situated alongside our bindery division, Hammonds for maximum efficiency. Continuous investment means the Charlesworth’s services continue to develop in order to serve the changing needs of our clients. Our press room and bindery remain equipped with the latest machinery to deliver rapid turnaround yet still provide the best possible quality services at competitive prices.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Dice Medical Communications Logo

Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.

View Profile

Advertising, Branding, Conference/meetings/events, Creative and design, Digital communications, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Sales, Training

- PMLiVE

Innovative Trials

Innovative Trials is a leading global clinical trial patient recruitment company. With over 10 years’ of experience, Innovative Trials deploys ‘boots-on-the-ground’ recruitment experts in over 70 countries, addressing individual sites’…

View Profile

Sales

Company Details

The Charlesworth Group (USA)
3624 Market St 5E, Philadelphia, Pennsylvania, 19104, United States
(00) +1 2159221611
Contact The Charlesworth Group (USA)
Website

 Latest Content from PMHub 

Article: Getting their lives back: Improving options for people with Lupus

White Papers and Resources | July 14, 2022 | Inizio

Head of Therapy Watch, Helen Parfitt and Head of Living With, Mariel Metcalfe, investigate Lupus from the perspective of both healthcare professionals and patients using data from our syndicated products.

HOW DID COVID-19 AFFECT PRESCRIBING BEHAVIOURS? FIVE KEY FINDINGS FROM A NEW STATE OF THE NATION REVIEW

Press Releases | July 14, 2022 | Wilmington Healthcare

Published earlier this month, Wilmington Healthcare’s new State of the Nation report draws on a raft of data from across primary and secondary care to show what actually happened to...

Accelerating patient recruitment post-COVID-19

White Papers and Resources | July 12, 2022 | Innovative Trials

COVID-19 has hugely affected clinical trials and patient recruitment, with the entire industry on hold for some time causing backlogs and delays most of the studies.

Genesis Research Acquires Market Access Transformation

Press Releases | July 11, 2022 | Genesis Research Group

Genesis Research, a leading provider of tech-enabled Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) services, has entered into a definitive agreement to acquire Market Access Transformation (“MAT”),...

Bedrock’s Accelerated Virtual Consensus Programme for Merck wins at Communiqué Awards

Press Releases | July 11, 2022 | Bedrock Healthcare Communications

The award recognises outstanding achievement in flexing thinking and processes to ensure success.

ISPOR 2022: a retrospective

Videos and Podcasts | July 11, 2022 | Genesis Research Group

Genesis Research – an introduction

Videos and Podcasts | July 11, 2022 | Genesis Research Group

Ensuring fit-for-purpose real-world data to generate real-world evidence with Susan Oliveria

Videos and Podcasts | July 11, 2022 | Genesis Research Group

Genesis Research at the World EPA Congress 2022

Videos and Podcasts | July 11, 2022 | Genesis Research Group

Traversing the Medtech Regulatory Landscape in the Interest of Patients

Videos and Podcasts | July 7, 2022 | Impetus Digital

Dr. Bassil Akra, CEO of AKRA TEAM GmbH, takes a deep dive into the new approval process for medical devices in the EU and shares how his company is supporting...